FOR HEALTHCARE PROFESSIONALS ONLY
Burning lungs in a bulb like a light

One minute to ignite new thinking in COPD

  1. Article
  2. Campus Sanofi
  3. Apr 1, 2024
Understanding type 2 inflammation may help shed light on why some patients continue to exacerbate. Watch this video to learn how.
Read more

Latest COPD articles

A video series on round table discussions featuring experts: Different inflammatory pathways in COPD impacting disease pathobiology and progression

The article "How do different inflammatory pathways in COPD impact disease pathobiology and progression?" features insights from a round table discussion involving leading respiratory experts. It focuses on chronic obstructive pulmonary disease (COPD), a heterogeneous and progressive condition. The experts delved into the inflammatory processes in COPD, particularly type 2 pathway and its associated endotype, emphasizing the importance of identifying patients by endotypes.

Learn more

A video series on round table discussions featuring experts: Current unmet needs for patients with COPD

The article "Current Unmet Needs for Patients with COPD" features insights from a round table discussion involving leading respiratory experts. It focuses on chronic obstructive pulmonary disease (COPD), a heterogeneous and progressive condition. The experts explore various aspects, such as the role of inflammatory pathways in disease progression, the importance of biomarkers in COPD management, and the significant global burden of COPD. The discussion also highlights the challenges in diagnosing COPD early, the impact of exacerbations on lung function and quality of life, and the need for more personalized treatment approaches .

Learn more

A review of the clinical implications of eosinophil stability and predictive capability in COPD

This article highlights the stability and predictive value of blood eosinophil levels in COPD, showing their strong link to exacerbation risk. Consistently elevated eosinophil levels can guide personalized treatment, including early use of inhaled corticosteroids (ICS). Integrating eosinophil measurements into routine practice can improve long-term disease management and patient outcomes.

Learn more